These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31443948)

  • 1. Autoantibodies in immune-mediated inflammatory neuropathies.
    Martín-Aguilar L; Pascual-Goñi E; Querol L
    Med Clin (Barc); 2019 Nov; 153(9):360-367. PubMed ID: 31443948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
    Collet R; Caballero-Ávila M; Querol L
    Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
    Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
    J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune peripheral neuropathies.
    Bourque PR; Chardon JW; Massie R
    Clin Chim Acta; 2015 Sep; 449():37-42. PubMed ID: 25748038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test.
    Pascual-Goñi E; Caballero-Ávila M; Querol L
    Neurology; 2024 Aug; 103(4):e209725. PubMed ID: 39088795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune-mediated neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):956-8. PubMed ID: 20030259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of immune-mediated neuropathies.
    Dalakas MC
    Biochim Biophys Acta; 2015 Apr; 1852(4):658-66. PubMed ID: 24949885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paranodal and other autoantibodies in chronic inflammatory neuropathies.
    Querol L; Illa I
    Curr Opin Neurol; 2015 Oct; 28(5):474-9. PubMed ID: 26263474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.
    Querol L; Devaux J; Rojas-Garcia R; Illa I
    Nat Rev Neurol; 2017 Sep; 13(9):533-547. PubMed ID: 28708133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
    Lim JP; Devaux J; Yuki N
    Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies.
    Vallat JM; Mathis S
    Brain Pathol; 2024 Mar; 34(2):e13184. PubMed ID: 37356965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances and perspectives in treatment for refractory neuropathies with special reference to immune-mediated neuropathies and Crow-Fukase syndrome].
    Kuwabara S
    Rinsho Shinkeigaku; 2010 Apr; 50(4):219-24. PubMed ID: 20411803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome.
    Yako K; Kusunoki S; Kanazawa I
    J Neurol Sci; 1999 Oct; 168(2):85-9. PubMed ID: 10526188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy in Peripheral Neuropathies.
    Léger JM; Guimarães-Costa R; Muntean C
    Neurotherapeutics; 2016 Jan; 13(1):96-107. PubMed ID: 26602549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies.
    Tobon A
    J Infus Nurs; 2017; 40(6):375-379. PubMed ID: 29112586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.